Skip to main content
SpringerLink
Log in

Effect of cholesterol-lowering diets on indices of depression and hostility

  • Other Empirical Articles
  • Published:
Annals of Behavioral Medicine

Abstract

Increased injury deaths have been reported among treatment groups in cholesterol lowering trials, leading to speculation that lipid lowering may result in behavioral disorders. We investigated this in 319 men enrolled in a 2-year trial of lipid lowering diets who completed measures of depression and hostility at entry and 24 months later. Mean Beck Depression Inventory (BDI) scores were lower after 24 months (3.8 versus 3.3,p<0.05) and Symptom Checklist 90-Revised (SCL-90) depression and hostility scores were unchanged. After adjustment for potential confounding, 24-month hostility and BDI scores were unrelated to lipid changes. A small inverse association of borderline statistical significance (B=0.034,p=0.08) was noted between 24-month SCL-90 depression scores and lipid changes. Lipid lowering diets had no significant adverse effect on psychological function and are consistent with current dietary recommendations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Criqui MH: Cholesterol, primary and secondary prevention, and all-cause mortality.Annals of Internal Medicine. 1991,115:973–976.

    PubMed  CAS  Google Scholar 

  2. Oliver MF: Reducing cholesterol does not reduce mortality.Journal of the American College of Cardiology. 1988,12:814–817.

    Article  PubMed  CAS  Google Scholar 

  3. Oliver MF: Doubts about preventing coronary heart disease.British Medical Journal. 1992,304:393–394.

    PubMed  CAS  Google Scholar 

  4. Frick MH, Elo O, Haapa K, et al: Primary prevention trial with gemfibrozil in middle-aged men with dyslipidemia.New England Journal of Medicine. 1987,317:1237–1245.

    PubMed  CAS  Google Scholar 

  5. Lipid Research Clinics Program: The Lipid Research Clinics Coronary Primary Prevention Trial results, I: Reduction in incidence of coronary heart disease.Journal of the American Medical Association. 1984,251:351–364.

    Article  Google Scholar 

  6. Wysowski DK, Gross TP: Deaths due to accidents and violence in two recent trials of cholesterol-lowering drugs.Archives of Internal Medicine. 1990,150:2169–2172.

    Article  PubMed  CAS  Google Scholar 

  7. Muldoon MF, Manuck SB, Matthews KA: Lowering cholesterol concentrations and mortality: A quantitative review of primary prevention trials.British Medical Journal. 1990,301:309–314.

    Article  PubMed  CAS  Google Scholar 

  8. Smith GD, Pekkanen J: Should there be a moratorium on the use of cholesterol lowering drugs?British Medical Journal. 1992,304:431–434.

    Google Scholar 

  9. Engelberg H: Low serum cholesterol and suicide.Lancet. 1992,339:727–729.

    Article  PubMed  CAS  Google Scholar 

  10. Mason RP, Herbette LG, Silverman DI: Can altering serum cholesterol affect neurologic function?Journal of Molecular and Cellular Cardiology. 1991,23:1339–1342.

    Article  PubMed  CAS  Google Scholar 

  11. Katz AM: Cholesterol and violent death.Journal of Molecular and Cellular Cardiology. 1991,23:1343–1344.

    Article  PubMed  CAS  Google Scholar 

  12. Virkkunen M: Serum cholesterol in antisocial personality.Neuropsychobiology. 1979,5:27–30.

    Article  PubMed  CAS  Google Scholar 

  13. Virkkunen M: Serum cholesterol levels in homicidal offenders.Neuropsychobiology. 1983,10:65–69.

    Article  PubMed  CAS  Google Scholar 

  14. Virkkunen M, Penttinen H: Serum cholesterol in aggressive conduct disorder: A preliminary study.Biological Psychiatry. 1984,19:435–439.

    PubMed  CAS  Google Scholar 

  15. Morgan RE, Palinkas LA, Barrett-Connor EL, Wingard DL: Plasma cholesterol and depressive symptoms in older men.Lancet. 1993,341:75–79.

    Article  PubMed  CAS  Google Scholar 

  16. Gallerani M, Manfredini R, Caracciolo S, et al: Serum cholesterol concentrations in parasuicide.British Medical Journal. 1995,310: 1632–1636.

    PubMed  CAS  Google Scholar 

  17. Freedman DS, Byers T, Barrett DH, et al: Plasma lipid levels and psychologic characteristics in men.American Journal of Epidemiology. 1995,141:507–517.

    PubMed  CAS  Google Scholar 

  18. Brown SL, Salive ME, Harris TB, et al: Low cholesterol concentrations and severe depressive symptoms in elderly people.British Medical Journal. 1994,308:1328–1332.

    PubMed  CAS  Google Scholar 

  19. Muldoon MF, Matthews KA, Wing RR: Serum cholesterol and depression in women.Circulation. 1994,89:6.

    Google Scholar 

  20. Weidner G, Connor SL, Hollis JF, Connor WE: Improvements in hostility, and depression in relation to dietary change and cholesterol lowering: The Family Heart Study.Annals of Internal Medicine. 1992,117:820–823.

    PubMed  CAS  Google Scholar 

  21. Lewis B, Tikkanen MJ: Low blood cholesterol and mortality: Causality, consequence, and confounders.American Journal of Cardiology. 1994,73:80–85.

    Article  PubMed  CAS  Google Scholar 

  22. Muldoon MF, Manuck SB: Health through cholesterol reduction: Are there unforeseen risks?Annals of Behavioral Medicine. 1992,14:101–108.

    Google Scholar 

  23. Cummings P, Psaty BM: The association between cholesterol and death from injury.Annals of Internal Medicine. 1994,120:848–855.

    PubMed  CAS  Google Scholar 

  24. Santiago JM, Dalen JE: Cholesterol and violent behavior.Archives of Internal Medicine. 1994,154:1317–1321.

    Article  PubMed  CAS  Google Scholar 

  25. Jacobs DR, Muldoon MF, Rastam L: Invited commentary: Low blood cholesterol, nonillness mortality, and other, nonatherosclerotic disease mortality: A search for causes and confounders.American Journal of Epidemiology. 1995,141:518–522.

    PubMed  Google Scholar 

  26. Kaplan JR, Manuck SB, Shively C: The effects of fat and cholesterol on social behavior in monkeys.Psychosomatic Medicine. 1991,53:634–642.

    PubMed  CAS  Google Scholar 

  27. Kaplan JR, Shively CA, Fontenot MB, et al: Demonstration of an association among dietary cholesterol, central serotonergic activity, and social behavior in monkeys.Psychosomatic Medicine. 1994,56:479–484.

    PubMed  CAS  Google Scholar 

  28. Anderson IM, Parry-Billings M, Newsholme EA, Fairburn CG, Cowen PJ: Dieting reduces plasma tryptophan and alters brain 5-HT function in women.Psychological Medicine. 1990,20:785–791.

    PubMed  CAS  Google Scholar 

  29. Golomb BA: Cholesterol and violence: Is there a connection?Annals of Internal Medicine. 1998,128:478–487.

    PubMed  CAS  Google Scholar 

  30. Knopp RH, Walden CE, Retzlaff BM, et al: Long-term cholesterol lowering effects of four different fat restricted diets in hypercholesterolemic and combined hyperlipidemic (CHL) men: The Dietary Alternatives Study.Journal of the American Medical Association. 1997,278:1509–1515.

    Article  PubMed  CAS  Google Scholar 

  31. Walden CE, McCann BS, Retzlaff B, et al: Alternative fat-restricted diets for hypercholesterolemia and combined hyperlipidemia: Feasibility, design, subject recruitment, and baseline characteristics of the Dietary Alternatives Study.Journal of the American College of Nutrition. 1991,10:429–442.

    PubMed  CAS  Google Scholar 

  32. Derogatis LR:SCL-90-R: Administration, Scoring, and Procedures Manual II. Towson, MD: Clinical Psychometric Research, 1992.

    Google Scholar 

  33. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression.Archives of General Psychiatry. 1961,4:561–571.

    PubMed  CAS  Google Scholar 

  34. McCann BS, Retzlaff BM, Dowdy AA, Walden CE, Knopp RH: Promoting adherence to low-fat, low-cholesterol diets: Review and recommendations.Journal of the American Dietetic Association. 1990,90:1408–1417.

    PubMed  CAS  Google Scholar 

  35. Beck AT:Depression: Clinical, Experimental, and Theoretical Aspects. New York: Harper & Row, 1967.

    Google Scholar 

  36. Oliver JM, Simmons ME: Depression as measured by the DSM-III and the Beck Depression Inventory in an unselected adult population.Journal of Consulting and Clinical Psychology. 1984,52:892–898.

    Article  PubMed  CAS  Google Scholar 

  37. Derogatis LR:SCL-90-R Version Manual-I. Baltimore, MD: Johns Hopkins University Press, 1977.

    Google Scholar 

  38. Derogatis LR:Clinical Psychopharmacology. Menlo Park, CA: Addison-Wesley, 1986.

    Google Scholar 

  39. Derogatis LR, Rickels K, Rock AF: The SCL-90 and the MMPI: A step in the validation of a new self-report scale.British Journal of Psychiatry. 1976,128:280–289.

    PubMed  CAS  Google Scholar 

  40. Markovitz JH, Smith D, Raczynski JM, et al: Lack of relations of hostility, negative affect, and high-risk behavior with low plasma lipid levels in the Coronary Artery Risk Development in Young Adults Study.Archives of Internal Medicine. 1997,157:1953–1959.

    Article  PubMed  CAS  Google Scholar 

  41. McCann BS, Bovbjerg VE, Brief DJ, et al: Relationship of self-efficacy to cholesterol lowering and dietary change in hyperlipidemia.Annals of Behavioral Medicine. 1995,17:221–226.

    Google Scholar 

  42. Scandinavian Simvastatin Survival Study Group: Randomised trial of cholesterol lowering in 4,444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S).Lancet. 1994,344:1383–1389.

    Article  Google Scholar 

  43. Shepherd J, Cobbe SM, Ford I, et al: Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia.New England Journal of Medicine. 1995,333:1301–1307.

    Article  PubMed  CAS  Google Scholar 

  44. Gould AL, Rossouw JE, Santanello NC, Heyse JF, Furberg CD: Cholesterol reduction yields clinical benefit: A new look at old data.Circulation. 1995,91:2274–2282.

    PubMed  CAS  Google Scholar 

  45. The Expert Panel: Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II).Journal of the American Medical Association. 1993,269:3015–3023.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Medical College of Virginia/Virginia Commonwealth University, Box 980306, 23298-0306, Richmond, VA

    Viktor E. Bovbjerg

  2. University of Washington School of Medicine, Washington, USA

    Barbara S. McCann, Barbara M. Retzlaff, Carolyn E. Walden & Robert H. Knopp

Authors
  1. Viktor E. Bovbjerg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Barbara S. McCann
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Barbara M. Retzlaff
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carolyn E. Walden
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Robert H. Knopp
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Preparation of this manuscript was supported in part by NIH grant HL28891 from the National Heart, Lung, and Blood Institute and NIH grant DK35816 (Clinical Nutrition Research Unit).

About this article

Cite this article

Bovbjerg, V.E., McCann, B.S., Retzlaff, B.M. et al. Effect of cholesterol-lowering diets on indices of depression and hostility. ann. behav. med. 21, 98–101 (1999). https://doi.org/10.1007/BF02895039

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02895039

Keywords

Search

Navigation